Pharmacotherapy of Autism and related disorders

Kelly Blankenship, Craig A. Erickson, Christopher J. McDougle

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Public awareness of pervasive developmental disorders (PDDs), including autistic disorder (autism), has been increasing. In parallel, results from research directed toward pharmacologic treatment of interfering symptoms associated with PDDs has escalated. This review will focus on controlled drug studies performed to treat the interfering symptoms of PDDs. These include hyperactivity/inattention, repetitive and stereotypic behavior, irritability (aggression, self-injury, severe tantrums) and core social impairment. A priority is placed on randomized, placebo-controlled trials when available. The side effects of the medications in this population are also discussed.

Original languageEnglish (US)
Pages (from-to)203-209
Number of pages7
JournalPsychiatric Annals
Volume40
Issue number4
DOIs
StatePublished - Apr 1 2010

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Pharmacotherapy of Autism and related disorders'. Together they form a unique fingerprint.

  • Cite this

    Blankenship, K., Erickson, C. A., & McDougle, C. J. (2010). Pharmacotherapy of Autism and related disorders. Psychiatric Annals, 40(4), 203-209. https://doi.org/10.3928/00485713-20100330-06